Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility
Abstract Isocitrate lyase (ICL), a potential anti-tubercular drug target, catalyzes the first step of the glyoxylate shunt. In the present investigation, we studied the conformational flexibility of MtbICL to better understand its stability and catalytic activity. Our biochemical results showed that...
Main Authors: | Harish Shukla, Rohit Shukla, Amit Sonkar, Tripti Pandey, Timir Tripathi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-01235-z |
Similar Items
-
Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2
by: Ram Prasad Bhusal, et al.
Published: (2019-10-01) -
Isocitrate lyase messenger RNA in Chorella
by: Nicholl, D. S. T.
Published: (1983) -
Potential Inhibitors for Isocitrate Lyase of Mycobacterium tuberculosis and Non-M. tuberculosis: A Summary
by: Yie-Vern Lee, et al.
Published: (2015-01-01) -
Identification of isocitrate lyase cDNA clones in Chlorella
by: O'Mullan, Catherine Anne
Published: (1988) -
The synthesis of isocitrate lyase messenger RNA and protein in chlorella
by: Dunham, S. M.
Published: (1979)